Ito Y - Search Results

1

RUNX3 is a novel negative regulator of oncogenic TEAD-YAP complex in gastric cancer.

Qiao Y, Lin SJ, Chen Y, Voon DC, Zhu F, Chuang LS, Wang T, Tan P, Lee SC, Yeoh KG, Sudol M, Ito Y. Qiao Y, et al. Among authors: ito y. Oncogene. 2016 May 19;35(20):2664-74. doi: 10.1038/onc.2015.338. Epub 2015 Sep 14. Oncogene. 2016. PMID: 26364597

2

RUNX3 protein is overexpressed in human basal cell carcinomas.

Salto-Tellez M, Peh BK, Ito K, Tan SH, Chong PY, Han HC, Tada K, Ong WY, Soong R, Voon DC, Ito Y. Salto-Tellez M, et al. Among authors: ito k, ito y. Oncogene. 2006 Dec 7;25(58):7646-9. doi: 10.1038/sj.onc.1209739. Epub 2006 Jun 12. Oncogene. 2006. PMID: 16767156

3

RUNX3 is multifunctional in carcinogenesis of multiple solid tumors.

Chuang LS, Ito Y. Chuang LS, et al. Among authors: ito y. Oncogene. 2010 May 6;29(18):2605-15. doi: 10.1038/onc.2010.88. Epub 2010 Mar 29. Oncogene. 2010. PMID: 20348954 Review.

4

RUNX3 is oncogenic in natural killer/T-cell lymphoma and is transcriptionally regulated by MYC.

Selvarajan V, Osato M, Nah GSS, Yan J, Chung TH, Voon DC, Ito Y, Ham MF, Salto-Tellez M, Shimizu N, Choo SN, Fan S, Chng WJ, Ng SB. Selvarajan V, et al. Among authors: ito y. Leukemia. 2017 Oct;31(10):2219-2227. doi: 10.1038/leu.2017.40. Epub 2017 Jan 25. Leukemia. 2017. PMID: 28119527 Free PMC article.

5

Runx3 expression in gastrointestinal tract epithelium: resolving the controversy.

Ito K, Inoue KI, Bae SC, Ito Y. Ito K, et al. Among authors: ito y. Oncogene. 2009 Mar 12;28(10):1379-84. doi: 10.1038/onc.2008.496. Epub 2009 Jan 26. Oncogene. 2009. PMID: 19169278

6

AML1(-/-) embryos do not express certain hematopoiesis-related gene transcripts including those of the PU.1 gene.

Okada H, Watanabe T, Niki M, Takano H, Chiba N, Yanai N, Tani K, Hibino H, Asano S, Mucenski ML, Ito Y, Noda T, Satake M. Okada H, et al. Among authors: ito y. Oncogene. 1998 Nov 5;17(18):2287-93. doi: 10.1038/sj.onc.1202151. Oncogene. 1998. PMID: 9811459

7

Runx3 plays a critical role in restriction-point and defense against cellular transformation.

Chi XZ, Lee JW, Lee YS, Park IY, Ito Y, Bae SC. Chi XZ, et al. Among authors: ito y. Oncogene. 2017 Dec 14;36(50):6884-6894. doi: 10.1038/onc.2017.290. Epub 2017 Aug 28. Oncogene. 2017. PMID: 28846108 Free PMC article.

8

RUNX3 acts as a tumor suppressor in breast cancer by targeting estrogen receptor α.

Huang B, Qu Z, Ong CW, Tsang YH, Xiao G, Shapiro D, Salto-Tellez M, Ito K, Ito Y, Chen LF. Huang B, et al. Among authors: ito k, ito y. Oncogene. 2012 Jan 26;31(4):527-34. doi: 10.1038/onc.2011.252. Epub 2011 Jun 27. Oncogene. 2012. PMID: 21706051 Free PMC article.

9

Runx3 is required for the differentiation of lung epithelial cells and suppression of lung cancer.

Lee KS, Lee YS, Lee JM, Ito K, Cinghu S, Kim JH, Jang JW, Li YH, Goh YM, Chi XZ, Wee H, Lee HW, Hosoya A, Chung JH, Jang JJ, Kundu JK, Surh YJ, Kim WJ, Ito Y, Jung HS, Bae SC. Lee KS, et al. Among authors: ito k, ito y. Oncogene. 2010 Jun 10;29(23):3349-61. doi: 10.1038/onc.2010.79. Epub 2010 Mar 15. Oncogene. 2010. PMID: 20228843

10

Helicobacter pylori CagA targets gastric tumor suppressor RUNX3 for proteasome-mediated degradation.

Tsang YH, Lamb A, Romero-Gallo J, Huang B, Ito K, Peek RM Jr, Ito Y, Chen LF. Tsang YH, et al. Among authors: ito k, ito y. Oncogene. 2010 Oct 14;29(41):5643-50. doi: 10.1038/onc.2010.304. Epub 2010 Aug 2. Oncogene. 2010. PMID: 20676134 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12,120 results

Search Page

Filters